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Abstract To evaluate the accuracy of a neck-worn device
in measuring sleep/wake, detecting supine airway position,
and using loud snoring to screen for obstructive sleep
apnea. Study A included 20 subjects who wore the neck-
device during polysomnography (PSG), with 31 records
obtained from diagnostic and split-night studies. Study B
included 24 community-based snorers studied in-home for
up to three-nights with obstructive sleep apnea (OSA)
severity measured with a validated Level III recorder. The
accuracy of neck actigraphy-based sleep/wake was mea-
sured by assessing sleep efficiency (SE). Differences in
sleep position measured at the chest and neck during PSG
were compared to video-editing. Loud snoring acquired
with an acoustic microphone was compared to the apnea-
hypopnea index (AHI) by- and acrosspositions. Over-
reported SE by neck actigraphy was inversely related to
OSA severity. Measurement of neck and chest supine
position were highly correlated with video-edits (r = 0.93,
0.78). Chest was bias toward over-estimating supine time
while the majority of neck-device supine position errors
occurred during CPAP titrations. Snoring was highly cor-
related with the overall, supine, and non-supine PSG-AHI
(r = 0.79, 0.74, 0.83) and was both sensitive and specific
in detecting overall, supine, and non-supine PSGAHI [10
(sensitivity = 81, 88, 82 %; specificity = 87, 79, 100 %).
At home sleep testing-AHI [ 10, the sensitivity and
specificity of loud snoring was superior when users were
predominantly non-supine as compared to baseline (sensi-
tivity = 100, 92 %; specificity = 88, 77 %). Neck actig-
raphy appears capable of estimating sleep/wake. The
accuracy of supine airway detection with the neck-device
warrants further investigation. Measurement of loud snor-
ing appears to provide a screening tool for differentiating
positional apneic and benign snorers.
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1 Introduction
It has been estimated that the worldwide prevalence of
snoring ranges from 30 to 50 % of the adult population
[1–9]. The odds of being a habitual snorer are greater in
men [1, 3, 8, 9], with the prevalence further increased by
age [1, 3, 7, 10], weight [1, 5, 6], alcohol consumption [1,
5], and/or when pregnant [11–14]. Snoring is an inde-
pendent risk factor for obstructive sleep apnea (OSA) [15,
16]. Approximately 50 % of those who snore are likely to
have OSA [17–20], and a substantial majority is undiag-
nosed [20]. The vibrations caused by heavy snoring have
also been suggested as an independent risk factor for
carotid atherosclerosis [21–24]. Of the 15–25 % of the
adult population who are benign snorers [i.e., apnea-
hypopnea index (AHI) \ 5], most snore predominantly in
the supine position [25, 26].
Recognition of the clinical importance of OSA risk
factors and treating OSA is increasing worldwide, however
an inexpensive, objective tool to differentiate those in need
of a diagnostic sleep study from those with just benign
snoring remains elusive. Such a tool might also be useful
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for large epidemiological assessments of snoring and OSA
prevalence, the impact of snoring on cardiovascular dis-
ease, or the changes in snoring during pregnancy.
Previous reports suggest that the measurement of snor-
ing with an acoustic microphone holds potential for non-
invasively estimating sleep disordered breathing severity
[27–31]. Fiz et al. [28] found that as AHI severity increa-
ses, the acoustics change, suggesting the maximum snoring
frequency is reduced, the mean snoring intensities increase,
and the ratio between the 100 and 500 Hz power expand.
With respect to identifying excess tissue associated with
airway collapse, fast-Fourier transform of high frequency
snoring showed that palatal snoring lies in the lower fre-
quencies of the sound spectrum with snoring frequencies
increase stepwise from pharyngeal lateral wall, tongue
based, and epiglottis obstruction [32]. Mikami et al. [30]
showed that the fundamental frequency and maximum
amplitudes in frequency spectrum can be used to distin-
guish oral snoring sounds in patients with and without
sleep apnea. Fiz et al. [28] reported that receiver operating
curves using acoustic snoring could provide sensitivities
and specificities of 98.0 and 71.4 for an AHI C 5 and 80.0
and 90.0 for AHI C 15 so long as sleeping position was
factored into the snoring parameters. Abeyratne et al. [33]
validated a OSA screening tool that used a multi-feature
class analysis of snoring sounds acquired during laboratory
polysomnography that provided sensitivities and specifici-
ties of 93 % with an AHI cut-off of 15 events/h. Ben-Israel
et al. [27] achieved a sensitivity of 0.87 and a specificity
0.80 with a non-contact microphone placed 1 meter above
the bed at a sleep center.
Measuring the influence of position on snoring and/or
OSA is important given 65 % of benign snorers are posi-
tional and over 70 % of patients with mild to moderate OSA
are twice as severe supine as compared to non-supine [25].
Assessing snoring patterns relative to position may prove
useful in monitoring outcomes with position restriction
treatment, as well as other OSA therapies.
This report provides a description of a neck-worn device
and a retrospective assessment of its capability to accu-
rately measure sleep position and sleep/wake, and differ-
entiate benign snorers from those with clinically relevant
OSA.
2 Methods
2.1 Description of neck-device
The battery-powered, neck-worn device (Night ShiftTM,
Advanced Brain Monitoring, Carlsbad, CA, USA) weighs
44 g and includes electronics housed in a 5.5 (l) 9 3.8
(w) 9 1.6 (h) cm enclosure affixed on the back of the neck
with an adjustable non-latex silicone rubber strap secured
by a magnetic clasp (see Fig. 1).
The neck-device measures snoring with a built-in
acoustic microphone (PUI audio POM-2246P). The raw
audio input is sampled at 2 kHz, and root mean square
(RMS) of the digitized signal (12-bit A/D) is calculated
using a 100 ms window. The resulting 10 Hz RMS signal
is additionally filtered with a 0.5 Hz LP Butterworth 4th
order filter. A snore algorithm quantifies each snore based
on shape (attack, plateau and decline) and the peak
amplitude, prior to conversion to dB. Decibel calibration
was performed using a sound level meter and recorded
snoring sounds at 12 cm. Snores[40 and 50 dB are tallied
across each 30-s epoch. Loud snoring is defined as at least
one snore with a magnitude C50 dB.
The percentage of time snoring [50 dB is then deter-
mined for overall, supine, and non-supine epochs charac-
terized as sleep by actigraphy. Snoring indicative of
clinically relevant sleep disordered breathing is based on
[50 dB snoring in C10 % of neck-based sleep time.
A three-axis accelerometer is used to measure neck
position and actigraphic sleep versus wake. Neck positions
are reported as upright, supine, lateral left, lateral right, and
prone. Upright is assigned when the neck angle is C60.
Supine is assigned when the neck angle to the left/right is
\43. Lateral left or right was assigned when the neck
angle exceeded 47. The device remained in the previously
assigned position when the neck angle fell between 43 and
47. Prone is the mirrored position of supine with the
additional requirement that the Z axis is \-15. If the
device is worn upside down, the supine position will be
accurately measured however lateral left and right will be
inversed.
Sleep versus wake is measured in 30-s epochs using a
threshold applied to the median filter output derived from
the three X, Y, and Z signals. If any of the three signals
have an angle \50 and exceeds the actigraphy threshold,
the epoch is classified awake. Periods with gross movement
extend the wake classification for up to 3 epochs. The
initial 10-min after the device is turned on is automatically
classified as wake.
Two 9 1G haptic motors optionally provide vibro-tac-
tile feedback when the supine position is detected.
Fig. 1 Photograph of neck-device from a back and b front
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Positional feedback, initiated at a very low frequency/
duration, is gradually increased until the user exits the
supine position. When used for positional therapy, vibro-
tactile feedback is defaulted to initiate 15-min after the
device is turned on, to allow the user time to fall asleep.
The user can optionally delay feedback for 30-min or set
the device for immediate feedback. The device can also be
used only as a recorder with positional feedback disabled.
Data are acquired and analyzed in real time with derived
measures for sleep/wake, snoring magnitude, and position
for each 30-s epoch saved to the microcontroller flash
memory. The memory can store up to six nights’ of
detailed snoring, sleep, and position measures (one set of
values for each 30-s epoch), summary of key daily
parameters by month for 4 months, and the average values
across the days in the month for 12 months. This infor-
mation is accessed via assessment/compliance reports
generated in HTML format from a web-enabled portal. The
neck-device can record and provide vibro-tactile feedback
for three nights before charging is required.
For this study, prototype devices were used that allow
raw data to be saved to a memory card for off-line analysis
using software which allows the records to be
synchronized.
2.2 Study A
Consecutive volunteers scheduled for laboratory polysom-
nography (Complete Sleep Solutions, Murrieta, CA, USA)
between the ages of 18 and 75 with a body mass index (BMI)
\35 were recruited to wear the neck-device. Twenty
subjects were consented under a protocol approved by the
Chesapeake Institutional Review Board (IRB). This cohort
included fifteen males and five females with a mean age of
46 ± 13.2 years and a mean BMI of 29 ± 4.1 kg/M2.
For this study, the neck-device was set to record mode
(i.e., no positional feedback). The device was applied and
turned on by the technician. Patients were instructed to sit
upright in bed for 1 min just prior to lights out and just
after lights on, to provide a means to synchronize the
polysomnography (PSG) and the neck-device records.
The sleep studies were conducted and scored according
to the American Academy of Sleep Medicine (AASM)
criteria with 3 % hypopnea desaturation [34]. Alice three
or five systems were used with Pro-Tech nasal pressure
transducers and Pro-Tech respiratory induced plethys-
mography effort sensors (Philips Respironics, Monroeville,
PA, USA), and either Pro-Tech or SleepMate (Ambu, Inc.
Glen Burke, MD, USA) actigraphy-based body (chest)
position sensors.
2.3 Study B
Twenty-five individuals responding to a newspaper
advertisement met the inclusion criteria of: (a) age between
30 and 85, (b) slept nightly with a bed partner who com-
plained about their snoring, and (c) were not currently
being treated with CPAP for OSA. Subjects were con-
sented with a protocol approved by the BioMed IRB. This
cohort included 14 males and 10 females with a mean age
of 44 ± 10.5 years and a mean BMI of 31 ± 7.7 kg/M2
(range 22–57). Eighty-four percent were identified as being
at high OSA risk by the STOP questionnaire [35] or by the
ARES questionnaire [36, 37], with conflicting results in
two cases. A prior diagnosis of OSA, high blood pressure
and/or depression was reported in 12, 12 and 23 % of the
cases, respectively.
Subjects were instructed to wear the neck-device con-
current with a multi-channel home sleep testing (HST)
device (ARESTM, SleepMed, Boca Raton, FL, USA) for
three nights. Night 1 was intended to provide a baseline, so
the neck-device was set to record mode. On nights 2 and 3,
the neck-device was set to feedback mode using pre-
liminary supine detection parameters which under-reported
supine sleep (e.g., neck angle \ 35 vs. \ 43).
The HST was affixed to the forehead and measured
airflow from a cannula and pressure transducer, pulse and
oximetry using reflective plethysmography, quantified
snoring (dB) with a calibrated acoustic microphone, and
head movement and head position by actigraphy. Auto-
mated scoring algorithms were applied off-line to compute
the AHI. Apneas, based on a 10-sec cessation of airflow
detected by the automated algorithms, were included in the
apnea-index (AI) and the AHI. Hypopnea events required a
50 % reduction and recovery in airflow, and a minimum
3.5 % reduction in SpO2 and at least a 1.0 % recovery.
Sleep time was determined behaviorally, based on actig-
raphy, snoring, and airflow patterns. The algorithms and
accuracy of the automated scoring used to calculate the
AHI have been previously reported [38–40].
Just prior to lights out, subjects were instructed to turn
both devices on and perform a slow, loud 10-count, cap-
tured by both acoustic microphones and used to synchro-
nize the records. Each morning subjects completed brief
surveys to assess their sleep quality.
2.4 Data analysis
2.4.1 Study A
The Alice software was used to export: (a) EDF files to
obtain epoch level resolution of chest position, (b) sleep
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stages for each epoch, (c) recording and sleep time, and
(d) apnea/hypopnea indexes by, and across, positions.
Technician notes from the video review were used to edit
the body position.
To compare PSG and neck-device epochs classifications
of sleep or wake and supine or non-supine, the clock times
from the files were aligned, with accurate synchronization
confirmed by the change to the upright position at the start
of the recording. Comparisons of sleep versus wake were
measured from lights out until lights on. Recording time
was used to compare percentage of supine time from the
chest and neck. Video recordings were reviewed to provide
the gold-standard for classification of the supine position
for both the chest and neck.
The overall percent time snoring C50 dB from the neck
(loud snoring) was computed during periods detected as
sleep by the neck actigraphy. From these sleep epochs, the
supine and non-supine percent times snoring C50 dB were
derived. Reporting of the percentage of positional time
snoring required a minimum of 12-min of neck actigraphy-
based sleep time.
For the 11 participants who underwent a split-night study,
snoring and AHI values were derived separately for the
diagnostic and the CPAP titration periods. ‘‘Appendix 1’’
provides line data for the 20 subjects and 31 records used for
analyses.
2.4.2 Study B
Prior to off-line analysis, both the HST and neck-device
files were opened to identify the segment of the ARES EDF
file which needed to be excluded so that the 10-counts were
aligned.
2.5 Statistical analyses
Pearson correlations and Bland–Altman plots were used
to characterize the association and differences between
the paired measures. Two-tailed t tests, which assumed
equal variances, were used to measure significant
between-measure differences. Cross-tabulations were used
to compute the sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) between
the overall, supine, and non-supine AHI and when loud
snoring (i.e., C50 dB) exceeded 10 % of sleep time.
Repeated measures analysis of variance (ANOVA) was
used to assess significant changes in percent time supine
across nights. Subjects identified with positional obstruc-
tive sleep apnea (POSA) required an overall AHI C 5 and
a supine/non-supine AHI ratio C 2.0 (based on [12-min
of positional sleep time).
3 Results
3.1 Study A
The mean (±SD) sleep efficiency (SE) based on electro-
physiology and actigraphy were 76.8 ± 12.3 and
81.8 ± 10.0 %, respectively. No significant differences in
SE were observed between PSG and the neck-actigraphy
during the diagnostic studies (73.8 ± 12.1 and 78.4 ± 10.9,
respectively) or during the CPAP trials (82.4 ± 11.1 and
87.9 ± 3.7 %). Moderate agreement was observed between
the PSG and neck actigraphy SE (r = 0.44). Neck actigraphy
bias toward over-reporting sleep time (Fig. 2.) decreased as
OSA severity increased. Biases of 9.9 % observed for those
with no OSA (AHI \ 5), 5.6 % for those with mild to
moderate OSA (AHI 5–29) and -4.9 for those with severe
OSA (AHI C 30).
Very strong, significant agreements were observed
between the video-edited supine position and those mea-
sured by chest and neck (r = 0.78 and 0.93 respectively)
(Fig. 3). When Subject 12 was removed, the correlation
between chest and video-edited chest increased from 0.78
to 0.88. The chest transducer over-reported supine time by
[5 % in six studies, with an average error of 80 min
(range 16–284). The average error in supine time decreased
to 39 min when subject 12 was removed. In six cases, the
absolute difference between supine time by neck position
and video exceeded 5 %. In four cases, supine sleep time
was over-reported by neck position by an average of
28 min (range 16–60 min), and in two cases, neck position
under-reported supine sleep time by 18 and 38 min. In only
two cases, the neck and chest were reported in conflicting



























Average Sleep Efficiency (SE)
Bias 4.9 +12.0% r = 0.44, p < 0.05
Fig. 2 Bland–Altman plot comparing sleep efficiency between PSG
and neck actigraphy
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additional 18 min supine based on the position of the neck;
subject 20 spent 15 additional minutes supine based on
chest position.
During the diagnostic studies, 30 % of the subjects
had an AHI \ 5. Significant agreements (p \ 0.0001)
were observed between the percentages of sleep time
snoring C50 dB from the neck and the overall, supine,
and non-supine AHI (r = 0.79, 0.74, and 0.83,
respectively).
For an overall AHI C 10, the sensitivity and specificity
of loud snoring (i.e., 50 dB for C10 % of sleep time) were
81 and 87 %, respectively, with a PPV and NPV of 87 and
81 % respectively. The sensitivity and NPV improved to
87 and 88 %, respectively, with a clinical cut-off of
AHI C 15. At an AHI C 5, the absence of loud snoring
effectively ruled out mild OSA in 92 % of the cases, and
the presence of loud snoring provided a 93 % probability
of correctly identifying those with OSA.
Loud snoring was more robust in identifying important
sleep disordered breathing in the non-supine position as
compared to the supine position. For a non-supine
AHI C 10, the sensitivity and specificity were 82 and
100 %, and the PPV and NPV were 100 and 90 %,
respectively. At an AHI C 15, the non-supine sensitivity
and specificity were 100 and 95 %. In the supine position,
the clinical cut-off AHI C 10 provided the optimal accu-
racy with a sensitivity, specificity, PPV, and NPV of 88,
79, 82, and 85 %, respectively (Table 1).
3.2 Study B
Of the 24 subjects who successfully completed night 1, 21
also completed night 2 and 19 completed night 3. All
available data were analyzed with the exception of one
subject excluded due to missing data on Night 1 baseline
(forgot to turn the device on) which limited comparisons to
feedback nights 2 and 3. Subjects 9 and 13 had missing
data on nights 2 and/or 3 due to not turning the neck-device
on. Subjects 19 and 21 turned the neck-device off on nights
2 and 3 due to complaints of repetitive buzzing. Subject 10
turned the HST off during night 3. ‘‘Appendix 2’’ provides
line data used for the analyses.
From this community-based cohort, 33 % were benign
snorers, 42 % had mild or moderate OSA, and 25 % had
severe undiagnosed OSA (i.e., overall AHI C 30). Signif-
icant differences were observed in the sleep time and SE
measured by HST and neck-actigraphy (p \ 0.05)
(Fig. 5a). Figure 5b confirms that the reduction in SE
accuracy, measured by neck actigraphy, was attributed to
very severe OSA and supported the addition of a SE
threshold to further characterize OSA with the neck device.
As was observed during PSG, a very strong agreement
was noted between those with loud in-home snoring plus a
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Bias -5.8 +14.9% Bias -1.0+9.9%r = 0.78, p < 0.0001 r = 0.93, p < 0.0001
(a) (b)






Fig. 4 Photos of two cases of gross under-reporting of supine by the
neck-device with a S22 misclassified as upright by neck and supine
by video, and b S12 misclassified as lateral by neck
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of SE and loud snoring thresholds (i.e., SE B 25 or snoring
C10 % of sleep time) were compared to HST-AHI sever-
ity, the accuracies were similar to those observed during
PSG. Specificities were slightly inferior at baseline, and
superior on nights 2 and 3 when subjects spent the majority
of time in the non-supine position. For an overall
AHI C 10 at baseline, the sensitivity and specificity of
loud snoring were 92 and 77 %, respectively, with a PPV
and NPV of 79 and 91 % respectively. For an AHI C 15,
the sensitivity and NPV improved to 100 and 100 %,
respectively, while the specificity and PPV decreased
slightly to 73 and 71 %, respectively. On nights 2 and 3,
the sensitivity, specificity, PPV and NPV for an AHI C 10
were 100, 88, 84, and 100 %, respectively (Table 2).
Sixty-nine percent of subjects with an AHI C 5 had
POSA at baseline based on forehead position. The associ-
ation between the percentage of sleep time supine reported
from the neck and forehead was moderate (r = 0.38) with
substantial variability (mean of differences 3 ± 26.7 %).
Feedback significantly reduced the percentage of time
supine on nights 2 and 3 based on neck position
(F = 13.75, p \ 0.0001) but not by forehead position.
4 Discussion
The purpose of this study was to evaluate the capabilities of a
neck-device which uses actigraphy to measure sleep/wake
and sleep position, and an acoustic microphone to record
loud snoring. Studies conducted during PSG provide the
gold-standard comparisons for the initial validation. Inclu-
sion of studies during CPAP titration provides a second
condition for assessment of sleep/wake, position, and snor-
ing in over half the cases. Results were then cross-validated
in-home with a community-based cohort of snorers across
multiple nights with and without supine avoidance feedback.
To our knowledge, this is the first report on the use of neck
actigraphy to detect sleep/wake. Typically, actigraphy accu-
racy is challenged by the over-estimation of sleep due to long
periods of inactivity. In OSA patients, actigraphy accuracy is
Table 1 Accuracy of loud
snoring ([10 % of neck-based
sleep time above 50 dB) in
detecting PSG-AHI C 5, 10,
and 15
Overall PSG-AHI Supine PSG-AHI Non-supine PSG-AHI
[5 (%) C10 (%) C15 (%) [5 (%) C10 (%) C15 (%) [5 (%) C10 (%) C15 (%)
Sensitivity 77.8 81.3 86.7 78.9 87.5 86.7 75.0 81.8 100.0
Specificity 92.3 86.7 87.5 81.8 78.6 73.3 100.0 100.0 95.0
PPV 93.3 86.7 86.7 88.2 82.4 76.5 100.0 100.0 88.9
















































r = 0.28, p < 0.05Bias-8.1 + 21.1% r = 0.78, p < 0.0001
(a) (b)
Fig. 5 a Bland–Altman plot between sleep efficiency (SE) measured by actigraphy from the neck and forehead HST across all nights, and
b correlation plots between HST-AHI and sleep efficiency (SE) by neck actigraphy across all nights
Table 2 Accuracy of loud snoring and SE in detecting HST-
AHI C 5, 10, and 15
Night 1: HST-AHI at
baseline














Sensitivity 70.6 91.7 100.0 85.0 100.0 100.0
Specificity 75.0 76.9 73.3 90.0 87.5 80.8
PPV 85.7 78.6 71.4 89.5 84.2 73.7
NPV 54.5 90.9 100.0 85.7 100.0 100.0
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challenged by correct identification of sleep fragmentation
and movement resulting from sleep-disordered breathing. For
the 31 comparisons, absolute SE errors exceeded 10 in 39 %
of the records. By way of comparison, wrist-actigraphy based
Actiwatch-64 and Fitbit reported measurement errors of 50
and 58 %, respectively, in 24 healthy subjects [41]. For those
with an AHI \ 5, the neck-device was equivalent in accuracy
to Actiwatch and superior to Fitbit in the over-reporting of
sleep (i.e., bias: 9.9 vs. 9.3 and 14.5 % respectively). The
strong association between over-reporting of wake neck ac-
tigraphy and severe OSA was more apparent in the home
studies. To achieve reasonable sleep/wake accuracy without
the benefit of off-line processing of multiple parameters (i.e.,
actigraphy, snoring, and airflow), the wake threshold for the
neck-device was set to twice the actigraphy threshold selected
for forehead HST. One limitation of this study was that many
conventional measures, such as sleep time, sleep latency, and
wake after sleep onset, were not reported due to the number of
split-night studies. A more rigorous validation of neck-ac-
tigraphy conducted during PSG studies with sleep times
exceeding 5 h will be reported elsewhere.
A second objective of this study was to compare sleeping
positions derived fromtransducers placed in different locations
(e.g., chest, neck and head). During PSG, a substantially
greater number of gross supine position detection errors were
observed for both chest and neck as compared to Bignold [42],
with both methods tending to over-report the supine position.
Measurement of supine position during CPAP titration pro-
vides one explanation for the discrepancy. Four of six gross
supine position errors by neck position, and two of six gross
errors by chest position, occurred while on CPAP when
patients tend to direct their head/neck toward the unit and then
settle into the same position for long periods of time. Sleeping
in a semi-upright position confounded both the chest and neck
transducers, with chest over-reporting the supine position by
284 min and neck under-reporting the supine position by
116 min. Considering the impact of position detection errors
within the construct of a feedback device, false-positive supine
detection may be interpreted as a nuisance and could contribute
to non-compliance. False-negative detection would potentially
result in non-efficacious treatment. Investigation of the false
negative neck device errors during CPAP titration showed the
neck was in the overlap range between supine and lateral with
the head and neck rotated by more than 30 and the airway in a
position less susceptible to collapse [43, 44]. A prospective
cross-validation of the accuracy of neck-based position
assessment will be reported separately.
A third objective of this study was to assess whether loud
snoring could be effective in screening for important sleep-
disordered breathing. We conducted this evaluation under
laboratory and home-based conditions, included at least
30 % of participants without sleep disordered breathing,
recruited from the community, and assessed patients under
treatment conditions (i.e., CPAP titration and position
restriction). In previous investigations, the percentage of
time snoring based on the magnitude and duration of each
snore[40 dB, but not[50 dB, was a significant predictor of
positional OSA and successful outcomes with oral appliance
therapy [15, 37, 44, 45]. Because snoring modulates across
hypopneas and terminates during apneas, cases were repor-
ted in which the percent time snoring increased with oral
appliance therapy when apneas were converted to hypop-
neas. We hypothesize that the strong association between
snoring and AHI across a wide range of OSA severities,
during both PSG and HST, resulted from a new approach
whereby entire 30-s epochs were assigned loud snoring when
at least one snore exceeded 50 dB in the duration. Including
only epochs classified as sleep may also have assisted in
improving snoring sensitivity and specificity.
Loud snoring for more than 10 % of the night was effective
in identifying important sleep disordered breathing across
conventional OSA clinical cut-offs and was more accurate
when subjects were in the non-supine position. During non-
supine sleep, the optimal sensitivity was obtained with PSG-
AHI C 15 (100 %) and optimal specificity obtained with
PSG-AHI C 5 % (100 %). During supine sleep, a cut-off of
PSG-AHI C 10 provided the highest sensitivity (88 %), with
PSG-AHI C 5 providing the best specificity (82 %). When a
HST-AHI C 10 was applied to the baseline sessions, the sen-
sitivity and specificity from loud snoring were 91 and 77 %,
respectively. When patients were predominantly non-supine
(i.e., nights 2 and 3), the accuracy improved to 100 and 88 %,
respectively. The accuracy in screening for OSA with the neck-
device was similar to approaches which utilized a non-contact
acoustic microphone [27, 33]. Unlike the non-contact snoring
approaches, the neck-device can estimate positional severity.
These findings suggest that the neck-device is capable of
identifying important sleep disordered breathing in most
cases. When loud snoring is measured with an acoustic
microphone in combination with actigraphy-based sleep
time from the neck, the SE must be considered in those
with very severe OSA. The addition of SE did not affect
the results obtained during PSG data because all SE were
above the minimum threshold. This finding may be
attributed to short-duration diagnostic sleep times resulting
from the obvious need to initiate CPAP therapy.
The improved AHI detection accuracy of loud snoring in
the non-supine position, during both PSG and HST, suggests
possible interaction between the acoustic microphone and
bed-coverings. Two false-negative findings did not appear to
be solely attributed to the pillow because snoring below the
loud snoring threshold was observed in both the supine and
non-supine positions. Conversely, a false-positive result from
loud snoring did not appear to be due to CPAP mask leakage
because CPAP pressure and AHI were both low. In most
cases, the vibration sounds above 50 dB seemed to be
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effective in assessing OSA severity at baseline and under
treatment conditions. Additional studies should be conducted
to investigate conditions which contribute to false-positive
and false-negative results. For example, it’s possible that long
duration apnea or hypopnea events contribute to false negative
results at AHI C 15. Additional profiling of snoring patterns
such as excluding snores which occur during movement, may
further improve the detection capability of this measure.
Given the high prevalence of loud snoring worldwide (see
‘‘Appendix 3’’), and the impact of undiagnosed OSA on both
co-morbidities and medical costs, the need exists for easy,
inexpensive, and accurate differentiation of benign snorers
from those who should undergo a diagnostic study for OSA.
As a screening tool, the results obtained with the neck-device
were comparable to a single-channel Apnea Link nasal
pressure device [45], with both devices capable of being self-
applied and worn in the home. The neck-device provided
superior sensitivity and specificity, as compared to Apnea-
Link during PSG, when clinical cut-offs of AHI C 5 and
C10 were applied and inferior detection accuracy when
AHI C 15 was used. One weakness of the neck-device is the
potential for cross talk from a snoring bed partner. Bench-
tests suggest that loud bed-partner snoring can exceed 40 dB
but rarely 50 dB. Unlike the ApneaLink, screening of apneic
and non-apneic snorers with the neck-device can include the
assessment of airway position by comparing overall snoring
time to supine and non-supine snoring time [25, 26].
Previous reports suggest that POSA is prevalent in 53 % of
patients with sleep disordered breathing (i.e., AHI C 5 plus
supine AHI at least two times greater than the non-supine AHI)
[48, 49]. In the Study A group, 70 % had an AHI C 5 while
45 % of the cohort was identified with POSA based on body
position. POSA prevalence would increase to 50 % and match
previous reports if subjects with supine/non-supine ratios of
1.9 and 1.8 were included. The conventional definition of
POSA (i.e., supine/non-supine ratio C2.0) has assumed a 4 %
desaturation criteria [25, 48–51]. A relaxed definition of POSA
may be necessary when a 3 % desaturation criteria is applied. It
would be expected that a greater number of non-supine events
would meet the AHI criteria given oxyhemoglobin desatura-
tion may be less severe when lung volume is somewhat larger.
The concordance between the neck-and-chest-derived
percentage of time supine was much stronger than neck and
forehead supine sleep times. The prevalence of POSA
detected by forehead position across a range of OSA
severities was similar to previous estimates of those with
mild to moderate OSA [48, 49]. Excessive measurement of
supine sleep may also explain why significant changes in
percent time supine from the neck were observed on nights
2 and 3 but not the forehead. As a result of the discrep-
ancies, the agreement between positional HST-AHI and
loud snoring were not compared. The accurate detection of
a supine airway from the forehead is difficult because the
head can be in the same angle with the torso either laterally
or supine. The algorithms defining the supine position of
the airway from the neck are less complicated due to its
more restricted rotation. Others have argued that both head
and trunk positions are clinically relevant in assessment of
OSA because neither exclusively define the position of the
airway [43, 44]. This study suggests that neck position may
provide an alternative approach to measuring the impact of
position on airway collapsibility.
One limitation of this study was the limited assessment of
the benefit of supine avoidance feedback. Study B was
designed as a usability study for the neck-device, not as a
treatment outcome study. It was not anticipated that a quarter
of the community-based snorers would have severe undiag-
nosed OSA and that finding supports the need for a simple,
inexpensive screening tool. Proper assessment of positional
feedback outcomes, such as those conducted by Van Maanen
et al. [49, 50] requires inclusion criteria limited to only those
with POSA. Our study with feedback did provide insight as to
conditions most conducive for vibro-tactile position therapy.
For example, the two subjects, who presumed the device was
not working properly because it buzzed every 20–30 min,
slept 100 % of the time on their back at baseline. Those who
sleep exclusively supine may require a longer training/adap-
tation period and/or non-compliance may be greater. A report
of neck strap being uncomfortable was from a female with a
54.6 cm neck circumference. It’s unclear whether she wore
the strap too tight, but it also suggests that extreme adipose
tissue around the neck may influence compliance. Given the
neck-device was designed to measure compliance, and can be
trialed with limited effort, these concerns may be manageable
with improved patient selection.
5 Conclusions
This report provides a full description of a neck-worn device
and an initial assessment of its capabilities. Results suggest
that neck actigraphy is capable of estimating sleep/wake and
may be useful in predicting severe OSA. Detection of the
supine airway by neck actigraphy was equivalent to the
measures obtained from the chest. The supine detection
accuracy of the neck-device supports further investigation
for use with supine-avoidance therapy. Comparison of loud
snoring, acquired with a neck-based acoustic microphone, to
the AHIs obtained by PSG and HST suggest sensitivities and
specificities equivalent to other simple screening tools. The
combination of position assessment and OSA severity holds
promise as a screening tool to differentiate positional apneic
and benign snorers.
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S2* Diag. 247 78.5 74.9 25.7 66.6 44.1 78.9 16.6 58.5 40.9 40.9 41.1 40.9
S2* CPAP Titr. 205 80.5 86.3 27.3 36.0 44.5 55.5 0.0 0.8 67.8 67.8 68.3 67.8
S3* Diag. 305 81.8 69.2 54.3 56.3 95.6 61.9 41.6 53.5 32.0 32.0 33.9 32.0
S3 CPAP Titr. 210 93.1 90.2 2.9 2.6 4.3 2.6 1.6 2.7 47.1 47.1 47.1 47.1
S4 Diag. 499 60.9 91.8 1.9 3.8 2.3 4.0 1.3 1.3 71.0 69.1 90.6 69.1
S5* Diag. 210 84.3 84.8 12.5 5.0 34.4 13.3 1.0 0.0 48.1 39.3 38.6 39.3
S5 CPAP Titr. 228 80.9 85.7 0.7 2.3 0.5 2.5 0.8 1.3 93.4 67.1 80.7 67.1
S6 Diag. 239 75.7 67.2 56.7 51.2 56.5 52.1 57.1 48.9 66.7 66.7 66.9 66.7
S6 CPAP Titr. 194 90.5 84.3 1.7 2.1 1.8 1.2 1.5 5.6 75.6 75.6 75.6 75.6
S11 Diag. 406 40.5 72.0 0.0 10.1 0.0 15.0 0.0 5.4 37.7 45.1 48.4 45.1
S12 Diag. 481 94.7 93.8 1.1 0.0 0.4 0.0 0.0 0.0 87.8 25.5 0.0 25.5
S13 Diag. 146 76.4 60.1 104.9 51.1 106.9 39.5 56.2 60.0 36.6 36.6 36.6 36.6
S13 CPAP Titr. 216 91.9 90.9 20.9 28.7 20.9 28.5 N/A N/A 99.8 99.8 99.8 99.5
S14* Diag. 211 57.1 62.6 26.4 24.2 65.5 44.6 11.7 17.5 33.2 19.7 20.9 19.7
S14 CPAP Titr. 187 60.7 81.8 3.2 9.8 0.0 11.1 3.2 9.7 15.0 15.0 15.2 15.0
S15 Diag. 455 72.2 81.8 5.1 1.2 4.8 1.4 6.9 0.0 84.7 86.2 85.9 86.2
S16 Diag. 248 77.8 66.0 60.6 55.8 86.3 66.0 48.1 47.2 49.8 50.0 58.5 50.0
S16* CPAP Titr. 227 82.6 88.7 23.9 13.5 28.9 13.5 4.7 N/A 80.0 80.0 100.0 80.0
S17 Diag. 409 71.5 91.3 3.5 4.7 6.5 8.5 0.8 1.3 48.3 44.9 44.5 44.9
S18 Diag. 433 81.3 87.3 2.0 0.3 3.0 0.2 1.6 0.3 42.0 42.0 62.8 45.7
S19 Diag. 169 70.7 64.9 80.3 62.7 N/A N/A 80.3 62.7 24.0 5.9 5.6 5.9
S19 CPAP Titr. 218 87.8 91.9 3.1 4.8 7.7 15.0 1.7 0.4 76.1 26.6 29.8 26.6
S20 Diag. 121 74.8 86.4 58.3 12.4 58.3 12.4 N/A N/A 98.3 98.3 98.3 98.3
S20 CPAP Titr. 253 91.7 92.5 1.6 2.4 2.4 4.7 0.0 0.0 66.8 66.8 53.4 61.1
S21* Diag. 348 59.3 72.1 20.6 1.0 32.8 0.9 12.8 1.0 47.3 43.4 44.0 43.4
S22* Diag. 194 71.9 89.7 80.4 47.6 104.2 53.7 45.0 37.8 62.9 62.9 62.9 62.9
S22 CPAP Titr. 207 63.0 83.7 1.8 2.6 2.7 0.8 0.0 3.7 64.3 64.3 35.5 64.3
S23* Diag. 435 74.3 86.7 19.0 1.1 25.8 0.8 12.6 1.4 51.6 51.6 52.1 51.6
S24* Diag. 171 86.5 80.5 59.4 74.6 90.6 51.9 38.5 95.2 47.1 47.1 47.1 47.1
S24* CPAP Titr. 237 83.3 91.1 5.8 30.2 10.4 53.7 0.0 0.0 55.3 55.3 55.5 55.3
S25 Diag. 403 85.5 84.5 1.6 2.3 5.0 1.5 0.9 3.1 47.6 47.6 48.9 47.6
POSA* Mean 275 76.8 81.8 24.7 21.5 31.6 23.2 15.4 18.5 58.0 52.3 53.2 52.2
SD 109 12.3 10.0 29.4 24.2 35.5 25.0 22.7 27.1 21.9 22.8 26.1 22.6
* Positional obstructive sleep apnea
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